News & Events
< Back to News Overview
Victor Windeyer appointed General Manager of Sunshine Heart Company Pty Ltd
30 / 05 / 2007
Sunshine Heart (ASX:SHC) today announced the appointment of Mr Victor Windeyer as General Manager of Sunshine Heart Company Pty Ltd (SHPL). SHPL is a wholly owned subsidiary of Sunshine Heart, Inc (SHC). Mr Windeyer will continue in his role as Chief Operating Officer (COO) of Sunshine Heart Inc.
The appointment of Mr Windeyer as SHPL's General Manager is recognition of the critical role of the Sydney-based operation within the operational and regulatory structure of SHC. Mr Windeyer joined Sunshine Heart in January 2006 after spending several years in a related role with another heart failure device company, Ventracor Ltd (VCR). At VCR, he was Program Manager for the VentrAssist Left Ventricular Assist Device. In addition, he has had experience in project management with Invetech Pty Ltd where he led a team developing a novel product in the histology market. Mr Windeyer has also worked as a mechanical engineer for Cochlear Limited, after graduating with a degree in Mechatronic Engineering from the University of Sydney.
"Victor has been a great asset to Sunshine Heart with his experience in medical device development as well as heart assist devices." said Sunshine Heart's CEO, Don Rohrbaugh. "This promotion will properly position Victor within the SHC organization and recognizes his significant contribution in the Company's recent advances towards initiating the US clinical trials". In this role he will be responsible for leadership of the growing Sunshine Heart team within Australia.
Victor Windeyer, along with CFO Brian Bolton, will continue to report to the CEO, Don Rohrbaugh, who is located at the company's Orange County, California office. Victor will concentrate on leadership of the Australian operations allowing the CEO to concentrate on strategic relationships and managing the commencement of the US clinical trial.
"I am looking forward to commencing my expanded role within Sunshine Heart" said Victor Windeyer. "It is very exciting to be part of the SHC team advancing an entirely new form of heart assist device onto the world market."
"Sunshine Heart is now positioned to achieve significant Company milestones" said Chairman, Malcolm McComas. "We have the new wearable C-PulseT Driver, a great group of US university-based teaching hospitals and will shortly submit the IDE request to the FDA to initiate the US clinical trial of the C-PulseT System in the second half of 2007."
The appointment of Mr Windeyer as SHPL's General Manager is recognition of the critical role of the Sydney-based operation within the operational and regulatory structure of SHC. Mr Windeyer joined Sunshine Heart in January 2006 after spending several years in a related role with another heart failure device company, Ventracor Ltd (VCR). At VCR, he was Program Manager for the VentrAssist Left Ventricular Assist Device. In addition, he has had experience in project management with Invetech Pty Ltd where he led a team developing a novel product in the histology market. Mr Windeyer has also worked as a mechanical engineer for Cochlear Limited, after graduating with a degree in Mechatronic Engineering from the University of Sydney.
"Victor has been a great asset to Sunshine Heart with his experience in medical device development as well as heart assist devices." said Sunshine Heart's CEO, Don Rohrbaugh. "This promotion will properly position Victor within the SHC organization and recognizes his significant contribution in the Company's recent advances towards initiating the US clinical trials". In this role he will be responsible for leadership of the growing Sunshine Heart team within Australia.
Victor Windeyer, along with CFO Brian Bolton, will continue to report to the CEO, Don Rohrbaugh, who is located at the company's Orange County, California office. Victor will concentrate on leadership of the Australian operations allowing the CEO to concentrate on strategic relationships and managing the commencement of the US clinical trial.
"I am looking forward to commencing my expanded role within Sunshine Heart" said Victor Windeyer. "It is very exciting to be part of the SHC team advancing an entirely new form of heart assist device onto the world market."
"Sunshine Heart is now positioned to achieve significant Company milestones" said Chairman, Malcolm McComas. "We have the new wearable C-PulseT Driver, a great group of US university-based teaching hospitals and will shortly submit the IDE request to the FDA to initiate the US clinical trial of the C-PulseT System in the second half of 2007."